Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Z Galper

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Cardiovascular Medicine|December 25, 2012
Antiplatelet therapy after coronary stentingBenjamin Z Galper, Laura Mauri
Missouri Medicine|September 20, 2018
Calcific Aortic Stenosis: New Approaches to an Old DiseaseJerry D Kennett, Benjamin Z Galper
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 22, 2024
Aortic valve replacement today: Outcomes, costs, and opportunities for improvementSameer Amin, Suzanne J Baron, Benjamin Z Galper
Plos One|October 1, 2015
Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling StudyBenjamin Z Galper, Y Claire Wang, Andrew J Einstein
American Heart Journal|April 15, 2018
Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance dataBenjamin Z Galper, David E Beery, Gregory Leighton, et al.
American Heart Journal|February 3, 2015
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stentsPallav Garg, Benjamin Z Galper, David J Cohen, et al.
Heart (British Cardiac Society)|May 31, 2015
Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysisZhi Jian Wang, Yu Jie Zhou, Benjamin Z Galper, et al.
JACC. Case Reports|October 24, 2025
Left Atrial Embolization During Transcatheter Mitral Valve in Mitral Annular Calcification: Successful Percutaneous Bailout Using an Atrial Septal Defect OccluderNoah Q Haroian, Rajeev R Samtani, John W Rhee, et al.
Coronary Artery Disease|January 25, 2019
Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary interventionBenjamin Z Galper, Matthew R Reynolds, Pallav Garg, et al.
Intensive Care Medicine|July 25, 2003
Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictorsDavid M Studdert, Michelle M Mello, Jeffrey P Burns, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Cardiovascular Medicine|December 25, 2012
Antiplatelet therapy after coronary stentingBenjamin Z Galper, Laura Mauri
Missouri Medicine|September 20, 2018
Calcific Aortic Stenosis: New Approaches to an Old DiseaseJerry D Kennett, Benjamin Z Galper
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 22, 2024
Aortic valve replacement today: Outcomes, costs, and opportunities for improvementSameer Amin, Suzanne J Baron, Benjamin Z Galper
Plos One|October 1, 2015
Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling StudyBenjamin Z Galper, Y Claire Wang, Andrew J Einstein
American Heart Journal|April 15, 2018
Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance dataBenjamin Z Galper, David E Beery, Gregory Leighton, et al.
American Heart Journal|February 3, 2015
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stentsPallav Garg, Benjamin Z Galper, David J Cohen, et al.
Heart (British Cardiac Society)|May 31, 2015
Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysisZhi Jian Wang, Yu Jie Zhou, Benjamin Z Galper, et al.
JACC. Case Reports|October 24, 2025
Left Atrial Embolization During Transcatheter Mitral Valve in Mitral Annular Calcification: Successful Percutaneous Bailout Using an Atrial Septal Defect OccluderNoah Q Haroian, Rajeev R Samtani, John W Rhee, et al.
Coronary Artery Disease|January 25, 2019
Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary interventionBenjamin Z Galper, Matthew R Reynolds, Pallav Garg, et al.
Intensive Care Medicine|July 25, 2003
Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictorsDavid M Studdert, Michelle M Mello, Jeffrey P Burns, et al.
Pageof 3